CLINICA BAVIERA S.A.CLINICA BAVIERA S.A.CLINICA BAVIERA S.A.

CLINICA BAVIERA S.A.

No trades
See on Supercharts
Market capitalization
‪505.41 M‬EUR
‪35.97 M‬EUR
‪224.92 M‬EUR
‪1.39 M‬
Beta (1Y)
0.39
Employees (FY)
‪1.47 K‬
Change (1Y)
+117 +8.67%
Revenue / Employee (1Y)
‪153.43 K‬EUR
Net income / Employee (1Y)
‪24.54 K‬EUR

About CLINICA BAVIERA S.A.


CEO
Eduardo Baviera Sabater
Headquarters
Madrid
Founded
1992
ISIN
ES0119037010
FIGI
BBG000PGB2C6
Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. It specializes in the treatment of glaucoma, cataract, vitreous and retinal detachment, and strabismus or squinting. The company was founded by Eduardo Baviera Sabater, Julio Baviera Sabater, Luis Miguel Raga, and Fernando Llovet Osuna on February 5, 1992 and is headquartered in Madrid, Spain.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CBAV is 31.4 EUR — it has increased by 0.32% in the past 24 hours. Watch CLINICA BAVIERA S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange CLINICA BAVIERA S.A. stocks are traded under the ticker CBAV.
CBAV stock has fallen by −2.21% compared to the previous week, the month change is a −9.62% fall, over the last year CLINICA BAVIERA S.A. has showed a 36.52% increase.
We've gathered analysts' opinions on CLINICA BAVIERA S.A. future price: according to them, CBAV price has a max estimate of 26.30 EUR and a min estimate of 26.30 EUR. Watch CBAV chart and read a more detailed CLINICA BAVIERA S.A. stock forecast: see what analysts think of CLINICA BAVIERA S.A. and suggest that you do with its stocks.
CBAV reached its all-time high on Oct 21, 2024 with the price of 39.5 EUR, and its all-time low was 3.6 EUR and was reached on Dec 14, 2012. View more price dynamics on CBAV chart.
See other stocks reaching their highest and lowest prices.
CBAV stock is 1.59% volatile and has beta coefficient of 0.39. Track CLINICA BAVIERA S.A. stock price on the chart and check out the list of the most volatile stocks — is CLINICA BAVIERA S.A. there?
Today CLINICA BAVIERA S.A. has the market capitalization of ‪505.37 M‬, it has decreased by −1.27% over the last week.
Yes, you can track CLINICA BAVIERA S.A. financials in yearly and quarterly reports right on TradingView.
CBAV net income for the last quarter is ‪4.05 M‬ EUR, while the quarter before that showed ‪12.41 M‬ EUR of net income which accounts for −67.34% change. Track more CLINICA BAVIERA S.A. financial stats to get the full picture.
CLINICA BAVIERA S.A. dividend yield was 5.53% in 2023, and payout ratio reached 57.64%. The year before the numbers were 6.03% and 58.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has ‪1.47 K‬ employees. See our rating of the largest employees — is CLINICA BAVIERA S.A. on this list?
Like other stocks, CBAV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLINICA BAVIERA S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLINICA BAVIERA S.A. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLINICA BAVIERA S.A. stock shows the buy signal. See more of CLINICA BAVIERA S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.